跳至主要内容
临床试验/ACTRN12621001622897
ACTRN12621001622897尚未招募2 期

Efficacy and safety of intra-articular botulinum toxin A versus corticosteroid injections in knee osteoarthritis: A randomised control trial

Stephanie Babic0 个研究点目标入组 100 人开始时间: 2021年11月29日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 o limit(—)
性别
All

入选标准

  • 1.Age more than or equal to 40 years.
  • 2.Diagnosis of knee OA confirmed on clinical exam and radiologically by Kellgren-Lawrence Grading Scale (Grade III or IV);
  • 3.Symptoms present for more than or equal to 6 months; and
  • 4.Ability to understand and participate in the trial.

排除标准

  • 1.Age less than 40 years;
  • 2.Any intra-articular injection within the past 12 months;
  • 3.History of trauma to the knee within the past 12 months;
  • 4.History of surgery to the knee within the past 12 months;
  • 5.Neuromuscular disorders (for example, myasthenia gravis, Lambert-Eaton, amyotrophic lateral sclerosis et cetera);
  • 6.Other knee arthropathy (for example, RA, gout et cetera);
  • 7.Lower extremity dysfunction due to a neurological or medical cause (for example, due to a cerebrovascular accident or traumatic brain injury, diabetic neuropathy et cetera);
  • 8.Serious coagulation disorders or anticoagulant use; and
  • 9.Pregnancy or breastfeeding.

研究者

发起方
Stephanie Babic

相似试验